B-Lymphocyte Immunotherapy in Islet Transplantation

NCT00468442 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

NIH

Sponsor class

Stopped Lack of efficacy

Conditions

Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL: Allogeneic Pancreatic Islet Cells
BIOLOGICAL: Antithymocyte globulin
BIOLOGICAL: Daclizumab
BIOLOGICAL: Rituximab
DRUG: Sirolimus

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]